Neurotransmitter interactions in schizophrenia–therapeutic implications

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131 · see citing works

Psychopharmacology: The Fourth Generation of Progress

Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985 · see citing works

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · see citing works

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · see citing works

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086 · see citing works

Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats

Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006 · see citing works

The current status of the dopamine hypothesis of schizophrenia

Carlsson, A. C. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 959 · see citing works

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

Abi-Dargham, A., Gil, R. B., Krystal, J., Baldwin, R., Seibyl, J., Bowers, M., van Dyck, C., Charney, D., Innis, R., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 860 · see citing works

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

Kim, J. S., Kornhuber, H. H., Schmid‐Burgk, W., & Holzmüller, B. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90178-0 · Cited by 694 · see citing works

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

Carlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258633 · Cited by 423 · see citing works

The role of 5-HT2A receptors in antipsychotic activity

Schmidt, C. J., Sorensen, S. M., Kenne, J. H., Carr, A. A., & Palfreyman, M. G. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00210-w · Cited by 215 · see citing works

Striatal D2 Dopamine Receptor Characteristics in Neuroleptic-Naive Schizophrenic Patients Studied With Positron Emission Tomography

Hietala, J. A. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020040004 · Cited by 176 · see citing works

Presynaptic dopaminergic function in the striatum of schizophrenic patients

Dao-Castellana, M. H., Martinot, M. P., Hantraye, P., Attar-Levy, D., Rémy, P., Crouzel, C., Eric Artiges, A., Féline, A., Syrota, A., & Martinot, J. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00102-8 · Cited by 160 · see citing works

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

Miller, D. W., & Abercrombie, E. D. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02144-2 · Cited by 146 · see citing works

Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems

Carlsson, M. L., & Svensson, A. I. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90123-y · Cited by 123 · see citing works

Muscimol: GABA agonist therapy in schizophrenia

Tamminga, C. A., Crayton, J. W., & Chase, T. N. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.6.746 · Cited by 115 · see citing works

substituted (S)-Phenylpiperidines and Rigid Congeners as Preferential Dopamine Autoreceptor Antagonists: Synthesis and Structure-Activity Relationships

Sonesson, C., Lin, C., Hansson, L. O., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00043a013 · Cited by 113 · see citing works

Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

Lahti, A. C., Weiler, M. A., Corey, P. K., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00030-9 · Cited by 104 · see citing works

Low brain uptake of L‐[11C]5‐hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers

Agren, H., Reibring, L., Hartvig, P., Tedroff, J., Bjurling, P., Hörnfeldt, K., Andersson, Y., Lundqvist, H., & Långström, B. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05574.x · Cited by 97 · see citing works

Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone

Martin, P., Waters, N., Schmidt, C. J., Carlsson, A., & Carlsson, M. L. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050064 · Cited by 86 · see citing works

The selective 5-HT2a receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse ? implications for psychosis

Carlsson, M. L. (1995) · Journal of Neural Transmission · doi:10.1007/bf01276460 · Cited by 86 · see citing works

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice

Carlsson, M. L., Martin, P., Nilsson, M., Sorensen, S. M., Carlsson, A., Waters, N., & Waters, N. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050144 · Cited by 78 · see citing works

(+)-UH 232 and (+)-UH 242: Novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors

Svensson, K. A., Hjorth, S., Clark, D. T., et al. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249608 · Cited by 43 · see citing works

On the Quantitative Structure-Activity Relationships of Meta-Substituted (S)-Phenylpiperidines, a Class of Preferential Dopamine D2 Autoreceptor Ligands: Modeling of Dopamine Synthesis and Release in Vivo by Means of Partial Least Squares Regression

Hansson, L. O., Waters, N., Holm, S., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a015 · Cited by 33 · see citing works

Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue

Hansson, L. ‐., Waters, N., Winblad, B. G., et al. (1994) · Journal of Neural Transmission · doi:10.1007/bf01276538 · Cited by 29 · see citing works

Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755

Waters, N., Lundgren, C., Hansson, L. ‐., & Carlsson, M. L. (1996) · Journal of Neural Transmission · doi:10.1007/bf01292621 · Cited by 25 · see citing works

Interfering with glutamatergic neurotransmission by means of MK-801 administration discloses the locomotor stimulatory potential of other transmitter systems in rats and mice

Carlsson, M. L., & Svensson, A. I. (1990) · Amino Acids · doi:10.1007/978-94-011-2262-7_56 · Cited by 9 · see citing works

Increased synthesis of dopamine in prefrontal cortex and striatum in drug-naive schizophrenic patients studied by use of C11-labelled I-DOPA and positron emission tomography (PET)

Lindström, L. H., Gefvert, O., Hagberg, G. E., et al. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)88535-0 · Cited by 9 · see citing works

Does Fast Dissociation From the Dopamine D ₂ Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140 · see citing works

Dopamine as a Prolactin (PRL) Inhibitor

Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983 · see citing works

The Computational Anatomy of Psychosis

Adams, R. A., Stephan, K. E., Brown, H. R., Frith, C. D., & Friston, K. J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00047 · Cited by 850 · see citing works

Dysfunction of ventral striatal reward prediction in schizophrenia

Juckel, G., Schlagenhauf, F., Koslowski, M., Wüstenberg, T., Villringer, A., Knutson, B., Wrase, J., & Heinz, A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.07.051 · Cited by 578 · see citing works

Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment

LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437 · see citing works

Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders

Moghaddam, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01362-2 · Cited by 392 · see citing works

Chemotherapy in Psychiatry

Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365 · see citing works

The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?

Meyer, U., Yee, B. K., & Feldon, J. (2007) · The Neuroscientist · doi:10.1177/1073858406296401 · Cited by 303 · see citing works

Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia

Kehrer, C. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.006.2008 · Cited by 287 · see citing works

Functional Dysconnectivity of Corticostriatal Circuitry as a Risk Phenotype for Psychosis

Fornito, A., Harrison, B. J., Goodby, E., Dean, A., Ooi, C., Nathan, P. J., Lennox, B. R., Jones, P. B., Suckling, J., & Bullmore, E. T. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1976 · Cited by 279 · see citing works

Circuit Mechanisms of Reward, Anhedonia, and Depression

Höflich, A., Michenthaler, P., Kasper, S., & Lanzenberger, R. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy081 · Cited by 253 · see citing works

Antioxidants as potential therapeutics for neuropsychiatric disorders

Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222 · see citing works

Left temporal lobe structural and functional abnormality underlying auditory hallucinations

Hugdahl, K. (2009) · Frontiers in Neuroscience · doi:10.3389/neuro.01.001.2009 · Cited by 112 · see citing works

Prefrontal and striatal glutamate differently relate to striatal dopamine: Potential regulatory mechanisms of striatal presynaptic dopamine function?

Gleich, T., Deserno, L., Lorenz, R. C., Boehme, R., Pankow, A., Buchert, R., Kuhn, S., Heinz, A., Schlagenhauf, F., & Gallinat, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0329-15.2015 · Cited by 62 · see citing works

Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography

van Berckel, B. N. M., Kegeles, L. S., Waterhouse, R., Guo, N., Hwang, D.-R., Huang, Y., Narendran, R., Van Heertum, R., & Laruelle, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300902 · Cited by 43 · see citing works

Effects of prenatal bacterial infection on cognitive performance in early childhood

Lee, Y. H., Papandonatos, G. D., Savitz, D. A., Heindel, W. C., & Buka, S. L. (2020) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12603 · Cited by 21 · see citing works

Neurochemical sex differences in adult ADHD patients: an MRS study

Endres, D., Tebartz van Elst, L., Maier, S. J., Feige, B., Goll, P., Meyer, S. A., Matthies, S., Domschke, K., Lange, T., Sobanski, E., et al. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0264-4 · Cited by 14 · see citing works

Increased risk of developing schizophrenia in animals exposed to cigarette smoke during the gestational period

Zugno, A. I., Oliveira, M. B., Mastella, G. A., Heylmann, A. S. A., Canever, L., Pacheco, F. D., Damazio, L. S., Citadin, S. A., de Lucca, L. A., Simões, L. R., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.010 · Cited by 6 · see citing works

[Dopamine D4-receptor variants, schizophrenia and clozapine therapy].

Ewald, H., Mors, N. P. O., & Rosenberg, R. (1996) · PubMed

Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical Appraisal

Bürki, H. R., Eichenberger, E., Sayers, A., et al. (1975) · Pharmacopsychiatry · doi:10.1055/s-0028-1094449 · Cited by 99 · see citing works

Basic Aspects of Neurotransmitter Function

Leonard, B. E. (2003) · doi:10.1002/0470871482.ch2 · Cited by 2 · see citing works

[A role for antipsychotic agents in the membrane hypothesis of schizophrenia?].

Skrede, S., & Holmsen, H. (2003) · PubMed · Cited by 1 · see citing works

Study and Manipulation of Neurotransmitter Function in Humans

Webster, R. A. (2001) · doi:10.1002/0470846577.ch14 · Cited by 1 · see citing works